Study hurts Myogen's stock, drug prospects (Help with drug addictions)

Study hurts Myogen's stock, drug prospects
Rocky Mountain News - Myogen Inc. s experimental drug ambrisentan helped patients with a potentially fatal lung disorder exercise longer. The shares fell as much as 4.3 percent after data showed the drug did not slow worsening illness. The study found that ambrisentan

Drug costs hurting elderly
Beaver County Times - Just mentioning the cost of prescription drugs is enough to make some people sick. Mike Hornick knows the feeling. On Monday, the pharmacist at Ernie's Pharmacy in Midland watched a woman in her 50s walk out without her medicine. She wasn't covered

Up Next
CBS News - DEATH OF A GENERAL The soldier convicted in the death of an Iraqi general tells Scott Pelley that the interrogation technique that led to the death was sanctioned. Harry Moses is the producer. THE ORPHANAGE Bob Simon visits an African

Stem Cells Could Boost Stroke Recovery
WKYT 27 - Abdominal Aneurism Achilled Tendon Tear ACL Tear Acne ADHD Allergies AIDS Alzheimers Disease Amniocentesis Angioplasty Ankylosing Spondylitis Anthrax Appendicitis Assisted Delivery Asthma Astigmatism Atrial Fibrillation Benign Prostate Hyperplasia

Somaxon Says Insomnia Drug Works in Trial
MSN MoneyCentral - SAN DIEGO (AP) - Somaxon Pharmaceuticals Inc. said on Monday results from its Phase III trial of Silenor demonstrated the drug is effective in treating insomnia. The company said the four-week trial showed that patients taking either a 3 milligram or